| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 6.640 | 13.023 | 6.388 | 12.493 | 12.532 | 12.494 | 12.424 |
| Total Income - EUR | - | - | 0 | 6.640 | 13.023 | 6.388 | 12.493 | 12.532 | 12.494 | 12.424 |
| Total Expenses - EUR | - | - | 114 | 349 | 376 | 363 | 372 | 371 | 367 | 365 |
| Gross Profit/Loss - EUR | - | - | -114 | 6.292 | 12.647 | 6.025 | 12.121 | 12.161 | 12.127 | 12.058 |
| Net Profit/Loss - EUR | - | - | -114 | 6.092 | 12.257 | 5.839 | 11.753 | 11.792 | 10.419 | 10.168 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tomulescu Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 149 | 6.434 | 12.774 | 18.372 | 12.090 | 12.844 | 13.995 | 10.710 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 553 | 1.085 | 1.065 | 1.041 | 9.923 | 1.041 | 1.035 |
| Cash | - | - | 149 | 5.881 | 11.689 | 17.307 | 11.049 | 2.921 | 12.953 | 9.675 |
| Shareholders Funds | - | - | -70 | 6.024 | 12.307 | 17.913 | 11.802 | 11.841 | 13.373 | 10.216 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 219 | 410 | 467 | 459 | 288 | 1.003 | 622 | 494 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Tomulescu Medical Srl